HY-14121-10mg
|
MedChemexpress LLC
|
MRS 1754 [CAS 264622-58-4]
|
|
COVID-19-immunoregulation
|
|
HY-14121-100mg
|
MedChemexpress LLC
|
MRS 1754 [CAS 264622-58-4]
|
|
COVID-19-immunoregulation
|
|
HY-14121-25mg
|
MedChemexpress LLC
|
MRS 1754 [CAS 264622-58-4]
|
|
COVID-19-immunoregulation
|
|
HY-14121-5mg
|
MedChemexpress LLC
|
MRS 1754 [CAS 264622-58-4]
|
|
COVID-19-immunoregulation
|
|
HY-14121-50mg
|
MedChemexpress LLC
|
MRS 1754 [CAS 264622-58-4]
|
|
COVID-19-immunoregulation
|
|
HY-14121-1mL
|
MedChemexpress LLC
|
MRS 1754 [CAS 264622-58-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-146388-10mg
|
MedChemexpress LLC
|
Mtb ATP synthase-IN-1 [CAS 2642394-38-3]
|
|
COVID-19-immunoregulation
|
|
HY-146388-100mg
|
MedChemexpress LLC
|
Mtb ATP synthase-IN-1 [CAS 2642394-38-3]
|
|
COVID-19-immunoregulation
|
|
HY-146388-25mg
|
MedChemexpress LLC
|
Mtb ATP synthase-IN-1 [CAS 2642394-38-3]
|
|
COVID-19-immunoregulation
|
|
HY-146388-5mg
|
MedChemexpress LLC
|
Mtb ATP synthase-IN-1 [CAS 2642394-38-3]
|
|
COVID-19-immunoregulation
|
|
HY-146388-50mg
|
MedChemexpress LLC
|
Mtb ATP synthase-IN-1 [CAS 2642394-38-3]
|
|
COVID-19-immunoregulation
|
|
HY-146388-1mL
|
MedChemexpress LLC
|
Mtb ATP synthase-IN-1 [CAS 2642394-38-3] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-42490-100mg
|
MedChemexpress LLC
|
N3-PEG3-CH2CH2COOH [CAS 1056024-94-2]
|
|
COVID-19-immunoregulation
|
|
HY-42490-50mg
|
MedChemexpress LLC
|
N3-PEG3-CH2CH2COOH [CAS 1056024-94-2]
|
|
COVID-19-immunoregulation
|
|
HY-109008-10mg
|
MedChemexpress LLC
|
Nacubactam [CAS 1452458-86-4]
|
|
COVID-19-immunoregulation
|
|
HY-109008-100mg
|
MedChemexpress LLC
|
Nacubactam [CAS 1452458-86-4]
|
|
COVID-19-immunoregulation
|
|
HY-109008-5mg
|
MedChemexpress LLC
|
Nacubactam [CAS 1452458-86-4]
|
|
COVID-19-immunoregulation
|
|
HY-109008-50mg
|
MedChemexpress LLC
|
Nacubactam [CAS 1452458-86-4]
|
|
COVID-19-immunoregulation
|
|
HY-109008-1mL
|
MedChemexpress LLC
|
Nacubactam [CAS 1452458-86-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-17639-1mg
|
MedChemexpress LLC
|
Navamepent [CAS 1251537-11-7]
|
|
COVID-19-immunoregulation
|
|
HY-17639-10mg
|
MedChemexpress LLC
|
Navamepent [CAS 1251537-11-7]
|
|
COVID-19-immunoregulation
|
|
HY-17639-25mg
|
MedChemexpress LLC
|
Navamepent [CAS 1251537-11-7]
|
|
COVID-19-immunoregulation
|
|
HY-17639-5mg
|
MedChemexpress LLC
|
Navamepent [CAS 1251537-11-7]
|
|
COVID-19-immunoregulation
|
|
HY-136409-10mg
|
MedChemexpress LLC
|
N-Decanoyl-L-homoserine lactone [CAS 177315-87-6]
|
|
COVID-19-immunoregulation
|
|
HY-136409-100mg
|
MedChemexpress LLC
|
N-Decanoyl-L-homoserine lactone [CAS 177315-87-6]
|
|
COVID-19-immunoregulation
|
|